Patheon Announces Board Change

Toronto, Canada (June 20, 2007) – Patheon Inc. announced today that George L. Ploder has resigned as a director of Patheon.

“We thank George for 15 years of dedicated service as a director of Patheon,” said Peter Green, Chairman of the Board of Directors.

The Board is engaged in the process of identifying a suitable replacement director and Audit Committee Chairman. 

ABOUT PATHEON

Patheon (TSX:PTI; www.patheon.com) is a leading global provider of drug development and manufacturing services to the international pharmaceutical industry. Patheon operates a network of 14 facilities in the United States, Canada and Europe, employing more than 5,200 people and serving a client base of 250 pharmaceutical and biotechnology companies.

For further information: Mr. Riccardo Trecroce, Chief Executive Officer, Tel:  (905) 812-6877, Fax:  (905) 812-6613, Email: rtrecroce@patheon.com; Mr. John Bell, Chief Financial Officer, Tel: (905) 812-6812, Fax:  (905) 812-6613, Email: john.h.bell@patheon.com; Ms. Shelley Jourard, Director, Corporate Communications, Tel:  (905) 812-6614, Fax:  (905) 812-6613; Email: sjourard@patheon.com.

-30-